J Cutan Pathol 2000; 27: 316–318. 88 Wu ML, Guitart J. Unusual neurotropism. Am J Dermatopathol 2000; 22: 468–469.
89 Johnson DF, Keppen M, Sitz KV. Metastatic CH5424802 mouse basal cell carcinoma in acquired immunodeficiency syndrome-related complex. JAMA 1987; 257: 340–343. 90 Garlassi E, Harding V, Weir J et al. Nonmelanoma skin cancers among HIV-infected persons in the HAART era. J Acquir Immune Defic Syndr 2012; 60: e63–65. 91 Motley R, Kersey P, Lawrence C et al. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002; 146: 18–25. 92 Rodriguez EA, Jakubowicz S, Chinchilla DA et al. Porokeratosis of Mibelli and HIV-infection. Int J Dermatol 1996; 35: 402–404. 93 Kotlarewsky M, Freeman JB, Cameron W, Grikmard LJ. Anal intraepithelial dysplasia and squamous carcinoma in immunosuppressed patients. Can J Surg 2001;
44: 450–454. 94 Welton ML, Sharkey FE, Kahlenberg MS. The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am 2004; 13: 263–275. 95 Pereira F, Carey W, Shibata H et al. Multiple nevoid malignant melanomas in a patient with AIDS: the role of proliferating cell nuclear antigen in the diagnosis. J Am Acad Dermatol 2002; 47(Suppl 2): S172–174. 96 Hoffmann C, Horst HA, Weichenthal M, Hauschild A. Malignant melanoma and HIV infection: aggressive course despite immune reconstitution. Onkologie 2005; 28: 35–37. 97 Agnieszka W, Kubica, BS, Brewer JD. Melanoma Cell Cycle inhibitor in immunosuppressed patients. Mayo Clin Proc 2012; 87: 991–1003. 98 Crum-Cianflone N, Hullsiek KH, Satter E et al. Cutaneous malignancies among HIV-infected persons. Arch Intern Med 2009; 169: 1130–1138. 99 Telfer NR, Colver GB, Morton CA; British Association of Dermatologists. ADP ribosylation factor Guidelines
for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35–48. 100 Rodrigues LK, Klencke BJ, Vin-Christian K et al. Altered clinical course of malignant melanoma in HIV-positive patients. Arch Dermatol 2002; 138: 765–770. 101 Sass U, Kolivras A, André J. Malignant ‘animal-type’ melanoma in a seropositive African man. J Am Acad Dermatol 2006; 54: 547–548. 102 Webster RM, Sarwar, N, Bunker CB, Brock CS. A case series of HIV-positive patients with malignant melanoma. J HIV Therapy 2007; 12: 75–78. 103 Wilkins K, Dolev JC, Turner R et al. Approach to the treatment of cutaneous malignancy in HIV-infected patients. Dermatol Ther 2005; 18: 77–86. 104 Chan SY, Madan V, Lear JT, Helbert M. Highly active antiretroviral therapy-induced regression of basal cell carcinomas in a patient with acquired immunodeficiency and Gorlin syndrome. Br J Dermatol 2006; 154: 1079–1080. 105 Honda KS. HIV and skin cancer. Dermatol Clin 2006; 24: 521–530. 106 Scott DR. Eradication of basal cell cancer in an HIV positive patient with topical imiquimod. J Drugs Dermatol 2004; 3: 602. 107 Han SY, North JP, Canavan T et al. Merkel cell carcinoma. Hematol Oncol Clin North Am 2012; 26: 1351–1374.